Process for the detection of nucleic acids
First Claim
1. Method for detection of a first nucleic acid sequence comprising contacting said sequence with a complementary nucleic acid probe under conditions favoring hybridization between said sequence and said probe, wherein said probe is a second nucleic acid sequence having bound thereto at least one steroid hapten selected from the group consisting of digoxin and digoxigenin, said steroid hapten being bound to said second nucleic acid sequence via a bridge of at least 4 atoms length at a position thereon which does not participate in formation of hydrogen bonds with said first sequence, contacting hybridized probe with a labelled antibody which specifically binds to said steroid hapten, and detecting said labelled antibody to detect said first nucleic acid sequence.
1 Assignment
0 Petitions
Accused Products
Abstract
For the detection of nucleic acids of definite sequence by hybridisation with a complementary nucleic acid probe which contains bound via a chemical bonding at least one hapten as labelling one uses, as hapten, a steroid which is bound via a bridge of at least 4 atoms length to at least one position of the nucleic acid probe which does not participate in hydrogen bridge formation and detects the hybridised probe via an in turn labelled anti-hapten antibody.
45 Citations
35 Claims
- 1. Method for detection of a first nucleic acid sequence comprising contacting said sequence with a complementary nucleic acid probe under conditions favoring hybridization between said sequence and said probe, wherein said probe is a second nucleic acid sequence having bound thereto at least one steroid hapten selected from the group consisting of digoxin and digoxigenin, said steroid hapten being bound to said second nucleic acid sequence via a bridge of at least 4 atoms length at a position thereon which does not participate in formation of hydrogen bonds with said first sequence, contacting hybridized probe with a labelled antibody which specifically binds to said steroid hapten, and detecting said labelled antibody to detect said first nucleic acid sequence.
-
28. Method for detection of a first nucleic acid sequence comprising:
-
(a) contacting said first nucleic acid with at least two oligonucleotide primers under conditions favoring hybridization between said first nucleic acid sequence and said primers, wherein the first primer comprises a first nucleotide sequence which is complementary to a part of a nucleic acid sequence of a DNA strand to be detected and wherein the second primer comprises a different second nucleotide sequence which is identical to a part of a nucleotide sequence of said DNA strand to be detected, (b) treating said mixture from (a) with a polymerase and deoxyribonucleotides under conditions favoring nucleic acid polymerization and in the presence of at least one deoxyribonucleotide having bound thereto at least one steroid hapten selected from the group consisting of digoxin and digoxigenin, said steroid hapten being bound to said deoxyribonucleotide via a bridge of at least 4 atoms length at a position thereon which does not participate in formation of hydrogen bonds with any other nucleotide, (c) subjecting said mixture of (b) at least once to a cycle of denaturing, hybridizing and polymerizing according to steps (a) and (b), (d) contacting said mixture from (c) with a labelled antibody which specifically binds to said steroid hapten, and (e) detecting said labelled antibody as a detection of said first nucleic acid sequence. - View Dependent Claims (29, 30)
-
-
31. Method for detection of a first nucleic acid sequence comprising:
-
(a) contacting said first nucleic acid with at least two oligonucleotide primers under conditions favoring hybridization between said first nucleic acid sequence and said primers, wherein the first primer comprises a first nucleotide sequence which is complementary to a part of a nucleic acid sequence to be detected and wherein the second primer comprises a different second nucleotide sequence which is identical to a part of said nucleotide sequence to be detected, (b) treating said mixture from (a) with a polymerase and deoxyribonucleotides under conditions favoring nucleic acid polymerization, (c) subjecting said mixture of (b) at least once to a cycle of denaturing, hybridizing and polymerizing according to steps (a) and (b), (d) repeating the cycle according to step (c) in the presence of at least one deoxyribonucleotide having bound thereto at least one steroid hapten selected from the group consisting of digoxin and digoxigenin, said steroid hapten being bound to said deoxyribonucleotide via a bridge of at least 4 atoms length at a position thereon which does not participate in formation of hydrogen bonds with any other nucleotide, (e) contacting said mixture from (c) with a labelled antibody which specifically binds to said steroid hapten, and (f) detecting said labelled antibody as a detection of said first nucleic acid sequence. - View Dependent Claims (32, 33)
-
-
34. A deoxyribonucleotide or ribonucleotide having bound thereto at least one steroid hapten selected from the group consisting of digoxin and digoxigenin, said steroid hapten being bound to said deoxyribonucleotide or ribonucleotide via a bridge of at least 4 atoms length at a position which does not participate in formation of hydrogen bonds with any other nucleotide.
-
35. A deoxyribonucleotide or ribonucleotide triphosphate having bound thereto at least one steroid hapten selected from the group consisting of digoxin and digoxigenin, said steroid hapten being bound to said deoxyribonucleotide or ribonucleotide via a bridge of at least 4 atoms length at a position which does not participate in formation of hydrogen bonds with any other nucleotide.
Specification